InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its third quarter 2023 financial results on November 7, 2023, before the market opens. The company will also hold a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results. To participate, dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast on the company's website. A replay of the call will be available for the next 90 days.

Investor Conference Call to be held 9:00 a.m. Eastern Time

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)-- InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2023 financial results on Tuesday, November 7, 2023, before the market opens.

The Company will also conduct a conference call for all interested parties on Tuesday, November 7, 2023 at 9:00 a.m. Eastern Time to discuss its financial results.

To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 1133909 through Tuesday, November 14, 2023.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Patient Services (formerly Integrated Therapy Services (“ITS”)), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Device Solutions (formerly Durable Medical Equipment Services (“DME Services”)), supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231031538480/en/

Joe Dorame, Joe Diaz & Robert Blum

Lytham Partners, LLC

602-889-9700

Source: InfuSystem Holdings, Inc.

FAQ

When will InfuSystem Holdings release its third quarter 2023 financial results?

InfuSystem Holdings will release its third quarter 2023 financial results on November 7, 2023, before the market opens.

When will the conference call to discuss the financial results take place?

The conference call to discuss the financial results will take place on November 7, 2023, at 9:00 a.m. Eastern Time.

How can I participate in the conference call?

To participate in the conference call, you can dial (833) 366-1127 or (412) 902-6773. Alternatively, you can listen via a live webcast on the company's website.

Will there be a replay of the conference call?

Yes, a replay of the conference call will be available for the next 90 days. You can access the replay by visiting the company's website or by calling (877) 344-7529 or (412) 317-0088, replay access code 1133909.